• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Kyprolis RSD Michael Kacer and Perry Monaco to be replaced by OBU management

Quote

anonymous

Guest
Will be removed from their duties and reps will be transitioned over to OBU management depending on territory. PI DMs will be next as consolidation continues. This is one of Laura Hamill's first items in her new role to streamline cost and operational efficiencies.
 




Select open legacy Onyx PI territories will be piloted by Amgen OBU reps if the OBU rep has been TP within the last 3 years and asks for the trial period. Sales training will run a few training sessions for the pilot experiment.
 




You are a fool. Too many Onyx people running away from this mess and not enough Amgen tools to fill the gaps. Wait till Exel takes another chunk.

This is a critical time with the brand on the heels of the new indication and launching the contract. Spotlight is on Ludwig to perform. He can't afford any major disruptions like the ones you suggest.
 




anonymous said:
You are a fool. Too many Onyx people running away from this mess and not enough Amgen tools to fill the gaps. Wait till Exel takes another chunk.

This is a critical time with the brand on the heels of the new indication and launching the contract. Spotlight is on Ludwig to perform. He can't afford any major disruptions like the ones you suggest.
Click to expand...


What is excel?

What contract?/contract reps? Or new formulary position?
 




anonymous said:
You are a fool. Too many Onyx people running away from this mess and not enough Amgen tools to fill the gaps. Wait till Exel takes another chunk.

This is a critical time with the brand on the heels of the new indication and launching the contract. Spotlight is on Ludwig to perform. He can't afford any major disruptions like the ones you suggest.
Click to expand...

You losers have no where to go! Amgen owns you 2nd rate reps! OBU will destroy you!

McDonalds is calling. Jeff Ludwig, Paulson, Hamill and Jensen will give you a reference as a toilet cleaner
 




anonymous said:
You are a fool. Too many Onyx people running away from this mess and not enough Amgen tools to fill the gaps. Wait till Exel takes another chunk.

This is a critical time with the brand on the heels of the new indication and launching the contract. Spotlight is on Ludwig to perform. He can't afford any major disruptions like the ones you suggest.
Click to expand...

Onyx employees including reps who stayed with Amgen are holding not only Kyprolis and the OBU back, but the entire company. All reps from Onyx should have been given the ax with rest of your loser colleagues from SSF.

Chicago will have you Amgenfied! You will now be our little bitch!
 




Onyx reps are now at great risk for to fully experience the Amgen corporate big pharma culture. No Steve Vickers or Shawn Melley to act as a barrier. Amgen senior management will be viewing every move with a fine tooth and comb if sales are not hitting the $1B mark. Your DMs will be under tremendous pressure and every call, and every minute of your day is closely being scrutinized by sales analytics with GPS tracking tools on the phone, Ipad, and cars.

I hope Amgen has a plan B to backfill the launch or a quick transition plan to integrate OBU reps into Kyprolis.
 




Exelixis, Inc. (EXEL) will not be hiring anyone with the words "Onyx Pharmaceuticals"on their resume. In fact, even Turing Pharma employees are more valued that you!
 




anonymous said:
I hope Amgen has a plan B to backfill the launch or a quick transition plan to integrate OBU reps into Kyprolis.
Click to expand...

As more and more Onyx reps leave and Onyx management dwindles, it's only going to make the rest of the Onyx crew want out even more. I would think that Kyprolis sales training is gearing up for training the OBU and sales leadership figuring out how to split accounts among the OBU so there is no lapse in coverage.

To be honest, given the uncertainty and low Onyx retention rates, Amgen should have ripped this band aid off with the rest of SSF Onyx. It's just a mediocre transition that will do nothing but stall progress on advancing Kyprolis.
 




Wow! OBU is filled with heartless, cold senior management and reps. I guess this is a reflection of how far from its little biotech roots Amgen has fallen. It seems like its worse than big pharma since big pharma knows its big pharma why Amgen still believes its biotech, nimble and innovative.
 




















anonymous said:
For those Onyx reps still left, must suck to be hated on by OBU. It's a shame that this is the new Amgen culture.
Click to expand...

Where have you been? It started after Aranesp issues of the mid 2000s and has gotten worse. It's been hateful for the last several years buddy. It's all about survival and the best way to do it is by throwing someone else under the bus or to steal someone elses credit.
 












Coach of the year must be a joke. Just heard who won from the Onyx side and a DSM who lost half his team including the #1 rep in the country won. How do you win if half your team left you in 2015 and sales are average, and no one respects you because you constantly act like a clown?
 








anonymous said:
Exelixis, Inc. (EXEL) will not be hiring anyone with the words "Onyx Pharmaceuticals"on their resume. In fact, even Turing Pharma employees are more valued that you!
Click to expand...

Obviously you have no idea what you are talking about.

I left Onyx on December 31 after collecting a 6+month severance, a cash payout on my RSU's and guaranteed full bonus!

I start at Exelixis mid-January.

Eat your heart out, you little worm!

Note to low life Amgenites, the "catcha" phrase for this post was, "one might read a... sign". Something none of you have been able to do otherwise you would have left this sinking ship while you had a good reputation. Just remember, when you check us out on LinkedIn, if our profile includes Onyx, "don't come a knocking"
 




Top Bottom
Back
Quote